Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hans Graffner
Interferon Beta-1a for the Maintenance of Remission in Patients With Crohn's Disease: Results of a Phase II Dose-Finding Study
BMC Gastroenterology
Medicine
Gastroenterology
Related publications
Methotrexate and Maintenance of Remission in Crohn's Disease
Canadian Journal of Gastroenterology
A Pilot Study on the Use of Interferon Beta-1a in Early Alzheimer’s Disease Subjects
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
Glutamine for Induction of Remission in Crohn's Disease
Cochrane Database of Systematic Reviews
Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a
Journal of Negative Results in BioMedicine
Genetics
Pharmacology
Molecular Biology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding Study
Journal of Clinical Pharmacology
Pharmacology
FRI0244 Low Dose of Rituximab Is Effective for Maintenance of Clinical Remission or Low Disease Activity in Patients With Rheumatoid Arthritis
A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials
Journal of the Royal Statistical Society. Series C: Applied Statistics
Uncertainty
Statistics
Probability
Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized Hovon-Nordic Lymphoma Group Phase Iii Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
